In March 2025, the company declared new strategies for a direct-to-buyer featuring of its Wegovy weight loss drug. The company established a brand new pharmacy, referred to as NovoCare, which would cost clients $499 per 30 days for entry to the drug, lower than fifty percent the price of the dru